Specific high-affinity saturable binding of [3H] R05-4864 to benzodiazepine binding sites in the rat cerebral cortex.
Specific high-affinity saturable binding of [3H] R05-4864 to benzodiazepine binding sites in the rat cerebral cortex.
复制标题
[3H] R05-4864 与大鼠大脑皮层中苯二氮卓结合位点的特异性高亲和力可饱和结合。
DOI:
10.1016/0014-2999(81)90405-2
复制
发表时间:
1981
影响因子:
5
通讯作者:
Yamamura,HI
中科院分区:
文献类型:
--
作者:
Schoemaker,H;Bliss,M;Yamamura,HI
Benzodiazepines bind with high affinity to pharmacologically relevant receptors in the mammalian brain. Initial studies indicated the presence of a single homogeneous population of benzodiazepine receptor sites. However, more recent studies have provided evidence for the existence of multiple benzodiazepine receptors in the rat brain (Klepner et al., 1979). Benzodiazepines also bind with high affinity to membranes of a variety of peripheral tissues, including the kidney (Braestrup and Squires, 1977; Regan et al., 1981). The benzodiazepine receptor present in these tissues differs from that labelled by [3H]-flunitrazepam in the brain. For example, clonazepam is a potent inhibitor of [3H]-flunitrazepam binding to brain membranes, but is virtually inactive in displacing [3H]-flunitrazepam from kidney membranes. On the other hand, the benzodiazepine Ro5-4864, a clinically active anxiolytic devoid of anxiolytic-like activity in most animal tests (Randall et al., 1974), is a potent inhibitor of the kidney binding sites but fails to show significant activity in the brain. Recently, radiolabelled Ro5-4864 with high specific activity has become available. As expected,[3H]-Ro5-4864 binds with high affinity (KD= 1.6 nM; manuscript in preparation) to membrane preparations of the rat kidney, from which it can be displaced by nanomolar concentrations of diazepam and flunitrazepam. We now report